⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17513045 | 1.00 | — | — | |
| SCHEMBL7944187 | 0.83 | — | — | |
| SCHEMBL300801 | 0.78 | IDO1 (0.31) | — | |
| SCHEMBL7941211 | 0.74 | — | — | |
| SCHEMBL11272288 | 0.74 | — | — | |
| SCHEMBL815828 | 0.57 | — | — | |
| SCHEMBL28090128 | 0.53 | — | — | |
| SCHEMBL1052145 | 0.50 | — | — | |
| SCHEMBL1052146 | 0.50 | — | — | |
| SCHEMBL19955877 | 0.50 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 416 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7935815-B2 | Imidazoyl pyridine compounds and salts thereof | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2011-05-03 | — | — | US | claimed |
| EP-3289495-B1 | METHOD TO REPRESENT METAL CONTENT IN CRUDE OILS, REACTOR FEEDSTOCKS, AND REACTOR PRODUCTS | ASPENTECH CORP (US) | 2024-05-29 | — | — | EP | disclosed |
| EP-3897921-B1 | METHOD FOR CO2 ADSORPTION ON METAL ORGANIC FRAMEWORK | UNIV MASSEY (NZ) | 2024-05-01 | — | — | EP | disclosed |
| US-11905303-B2 | Metal-organic frameworks for gas adsorption | MASSEY UNIVERSITY (NZ) | 2024-02-20 | — | — | US | disclosed |
| US-11879019-B2 | Dual-enzyme responsive peptides | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-01-23 | — | — | US | disclosed |
| US-11730826-B2 | Amphiphilic nanoparticles for delivery of CRISPR based therapy | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2023-08-22 | — | — | US | disclosed |
| US-11691949-B2 | Quinoline sulfonamide compounds and their use as antibacterial agents | OTAGO INNOVATION LIMITED (NZ) | 2023-07-04 | — | — | US | disclosed |
| US-20230190696-A1 | Pharmaceutical Formulation for Histone Deacetylase Inhibitors | MEDIVIR AB (SE) | 2023-06-22 | — | — | US | disclosed |
| US-20230139366-A1 | BRARTEMICIN ANALOGUES | VICTORIA LINK LIMITED (NZ) | 2023-05-04 | — | — | US | disclosed |
| US-11607399-B2 | Pharmaceutical formulation for histone deacetylase inhibitors | MEDIVIR AB | 2023-03-21 | — | — | US | disclosed |
| US-20030220368-A1 | Novel piperidine compouds and drugs containing the same | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2003-11-27 | — | — | US | disclosed |
| EP-1364952-A1 | BICYCLIC NITROGENOUS FUSED-RING COMPOUND | Eisai Co., Ltd. (JP) | 2003-11-26 | — | — | EP | disclosed |
| EP-1319659-A1 | PYRIDAZINONES AND TRIAZINONES AND MEDICINAL USE THEREOF | Eisai Co., Ltd. (JP) | 2003-06-18 | — | — | EP | disclosed |
| WO-2003047577-A2 | PHARMACEUTICAL COMPOSITIONS COMPRISING DIHYDROPYRIDINONE COMPOUNDS AND AN IMMUNOREGULATORY OR AN ANTIINFLAMMATORY AGENT AND THEIR USES | EISAI CO LTD (JP) | 2003-06-12 | — | — | WO | disclosed |
| EP-1308441-A1 | 2-AMINOPYRIDINE COMPOUNDS AND USE THEREOF AS DRUGS | Eisai Co., Ltd. (JP) | 2003-05-07 | — | — | EP | disclosed |
| US-20030078277-A1 | Fused heterotricyclic compounds, process for preparing the compounds and drugs containing the same | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2003-04-24 | — | — | US | disclosed |
| EP-1300396-A1 | 1,2-DIHYDROPYRIDINE COMPOUNDS, PROCESS FOR PREPARATION OF THE SAME AND USE THEREOF | Eisai Co., Ltd. (JP) | 2003-04-09 | — | — | EP | disclosed |
| EP-1254904-A1 | NOVEL PIPERIDINE COMPOUNDS AND DRUGS CONTAINING THE SAME | Eisai Co., Ltd. (JP) | 2002-11-06 | — | — | EP | disclosed |
| EP-1254895-A1 | NITROGENOUS CYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | Eisai Co., Ltd. (JP) | 2002-11-06 | — | — | EP | disclosed |
| EP-1238979-A1 | FUSED HETEROTRICYCLIC COMPOUNDS, PROCESS FOR PREPARING THE COMPOUNDS AND DRUGS CONTAINING THE SAME | Eisai Co., Ltd. (JP) | 2002-09-11 | — | — | EP | disclosed |